Natera
NTRA
$106.46
Share price
-1.88%
Change (1 day)
109.86%
Change (1 year)
Categories
Earnings for Natera (NTRA)
Earnings in 2023 (TTM): -$0.44 B
According to Natera's latest financial reports the company's current earnings (TTM) are -$0.44 B. In 2022 the company made an earning of -$0.55 B a decrease over its 2021 earnings that were of -$0.48 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Natera from 2014 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$0.44 B | -20.54% |
| 2022 | -$0.55 B | 16.07% |
| 2021 | -$0.48 B | 105.14% |
| 2020 | -$0.23 B | 86.97% |
| 2019 | -$0.13 B | -3.92% |
| 2018 | -$0.13 B | -5.63% |
| 2017 | -$0.14 B | 41.66% |
| 2016 | -$95.63 M | 36.07% |
| 2015 | -$70.28 M | 1264.03% |
| 2014 | -$5.16 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Vertex Pharmaceuticals VRTX | $4.42 B | -1,118.09% | 🇺🇸 USA |
 Prothena PRTA | -$0.2 B | -56.04% | 🇮🇪 Ireland |
 Paratek Pharmaceuticals
PRTK | -$43.71 M | -89.94% | 🇺🇸 USA |